SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-13-002033
Filing Date
2013-05-15
Accepted
2013-05-15 09:30:40
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051513.htm 10-Q 343318
2 EXHIBIT 31.1 exh_311.htm EX-31.1 12127
3 EXHIBIT 31.2 exh_312.htm EX-31.2 12175
4 EXHIBIT 32 exh_32.htm EX-32 7233
  Complete submission text file 0001171843-13-002033.txt   1689908

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT caps-20130331.xml EX-101.INS 100469
6 XBRL TAXONOMY EXTENSION SCHEMA caps-20130331.xsd EX-101.SCH 23206
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caps-20130331_cal.xml EX-101.CAL 29736
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caps-20130331_def.xml EX-101.DEF 92507
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE caps-20130331_lab.xml EX-101.LAB 165073
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caps-20130331_pre.xml EX-101.PRE 111505
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33560 | Film No.: 13844038
SIC: 2834 Pharmaceutical Preparations